Finasteride vs Trastuzumab Deruxtecan

Finasteride vs Trastuzumab Deruxtecan: Overview

This comparison examines the pharmacological differences between Finasteride and Trastuzumab Deruxtecan.

Mechanism of Action

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Pharmacokinetics

Half-life: Finasteride — 5-6 hours.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2.

Molecular Weight: Finasteride — 372.5490 g/mol.

Type: Finasteride — Small molecule; Trastuzumab Deruxtecan — Antibody drug conjugate.